Prolongation of ifosfamide elimination half-life in obese patients due to altered drug distribution View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1989-03

AUTHORS

M. J. Lind, J. M. Margison, T. Cerny, N. Thatcher, P. M. Wilkinson

ABSTRACT

The pharmacokinetics of intravenous ifosfamide were determined in 16 patients with carcinoma of the bronchus. In all 25% (4) of these patients were obese (i.e. greater than 20% over their ideal body weight). The terminal elimination half-life (t1/2 beta) was found to be higher in the obese group than in the control group (6.36 h, range 5.77-7.45 h) vs 4.95 h, range 1.82-6.48 h) (P less than 0.05). This prolongation of the elimination half-life was due to an increased volume of distribution (Vd beta) in the obese group (42.81 1, range 35.49-51.90 l) vs 33.70 l range (17.76-50.62 l) (P less than 0.05). There was therefore no significant difference in total plasma clearance between the obese and normal groups. No correlation of ifosfamide plasma half-life was observed with total body weight (TBW) or ideal body weight (IBW). However, a significant positive correlation was observed between the percentage of IBW and plasma half-life. A strong positive correlation was observed between IBW and the plasma clearance of ifosfamide. The Vd beta correlated with both TBW and the percentage of IBW, but not with IBW itself. When Vd beta was normalised for IBW, there was a strong positive correlation with the percentage of IBW, suggesting that ifosfamide distribution into the TBW is higher than that into the IBW. More... »

PAGES

139-142

References to SciGraph publications

  • 1986-09. Drug Disposition in Obese Humans in CLINICAL PHARMACOKINETICS
  • 1980. Mathematical Modelling and Computers in Endocrinology in NONE
  • 1985-04. Cimetidine clearance in the obese in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 1987-09. Effect of body weight on the pharmacokinetics of cyclophosphamide in breast cancer patients in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 1984-12. Prednisolone disposition in obese men in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 1982-04. Pharmacokinetics of Drugs in Obesity in CLINICAL PHARMACOKINETICS
  • 1986-01. Comparative activity of ifosfamide and cyclophosphamide in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/bf00692355

    DOI

    http://dx.doi.org/10.1007/bf00692355

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1015420877

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/2557169


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Clinical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adult", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antineoplastic Combined Chemotherapy Protocols", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Carcinoma, Non-Small-Cell Lung", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Chromatography, High Pressure Liquid", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Half-Life", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Ifosfamide", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Lung Neoplasms", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mesna", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Middle Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Obesity", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Time Factors", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Tissue Distribution", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "name": [
                "CRC Department of Medical Oncology, Christie Hospital and Holt Radium Institute, M20 9BX, Manchester, U.K."
              ], 
              "type": "Organization"
            }, 
            "familyName": "Lind", 
            "givenName": "M. J.", 
            "id": "sg:person.015422476532.69", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015422476532.69"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "name": [
                "Department of Clinical Pharmacology, Christie Hospital and Holt Radium Institute, M20 9BX, Manchester, U.K."
              ], 
              "type": "Organization"
            }, 
            "familyName": "Margison", 
            "givenName": "J. M.", 
            "id": "sg:person.01041042433.15", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01041042433.15"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "name": [
                "CRC Department of Medical Oncology, Christie Hospital and Holt Radium Institute, M20 9BX, Manchester, U.K."
              ], 
              "type": "Organization"
            }, 
            "familyName": "Cerny", 
            "givenName": "T.", 
            "id": "sg:person.01145564236.77", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145564236.77"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "name": [
                "CRC Department of Medical Oncology, Christie Hospital and Holt Radium Institute, M20 9BX, Manchester, U.K."
              ], 
              "type": "Organization"
            }, 
            "familyName": "Thatcher", 
            "givenName": "N.", 
            "id": "sg:person.015365270024.60", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015365270024.60"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "name": [
                "Department of Clinical Pharmacology, Christie Hospital and Holt Radium Institute, M20 9BX, Manchester, U.K."
              ], 
              "type": "Organization"
            }, 
            "familyName": "Wilkinson", 
            "givenName": "P. M.", 
            "id": "sg:person.01036570730.14", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036570730.14"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "https://doi.org/10.1002/1097-0142(197805)41:5<1715::aid-cncr2820410510>3.0.co;2-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001078895"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/0305-7372(85)90011-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001184954"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/art.1780281006", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001231073"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1111/j.1365-2125.1983.tb02258.x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1002330203"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/clpt.1985.66", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1003361973", 
              "https://doi.org/10.1038/clpt.1985.66"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.2165/00003088-198611030-00002", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1003570732", 
              "https://doi.org/10.2165/00003088-198611030-00002"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1006569257", 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/978-3-642-81401-3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1006569257", 
              "https://doi.org/10.1007/978-3-642-81401-3"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/978-3-642-81401-3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1006569257", 
              "https://doi.org/10.1007/978-3-642-81401-3"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/clpt.1984.263", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1006768078", 
              "https://doi.org/10.1038/clpt.1984.263"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf00570489", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1007459702", 
              "https://doi.org/10.1007/bf00570489"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf00570489", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1007459702", 
              "https://doi.org/10.1007/bf00570489"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s0140-6736(80)92703-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1009504814"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/0006-2952(74)90318-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013048117"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/0006-2952(74)90318-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013048117"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1111/j.1365-2125.1985.tb02799.x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1015146573"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/cpt1978234438", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1020458889"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf00647438", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1022888188", 
              "https://doi.org/10.1007/bf00647438"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf00647438", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1022888188", 
              "https://doi.org/10.1007/bf00647438"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s0305-7372(83)80002-4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1035035103"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.2165/00003088-198207020-00002", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1046808650", 
              "https://doi.org/10.2165/00003088-198207020-00002"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.2165/00003088-198207020-00002", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1046808650", 
              "https://doi.org/10.2165/00003088-198207020-00002"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/j.1552-4604.1981.tb01769.x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1049461852"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/bmc.1130010303", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1052597820"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/bmc.1130010303", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1052597820"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1210/jcem-24-9-832", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1064305784"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1075246971", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1076340409", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1079450294", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1200/jco.1988.6.8.1321", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1079730253"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1081346306", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1081583236", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1082156052", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1082228972", 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "1989-03", 
        "datePublishedReg": "1989-03-01", 
        "description": "The pharmacokinetics of intravenous ifosfamide were determined in 16 patients with carcinoma of the bronchus. In all 25% (4) of these patients were obese (i.e. greater than 20% over their ideal body weight). The terminal elimination half-life (t1/2 beta) was found to be higher in the obese group than in the control group (6.36 h, range 5.77-7.45 h) vs 4.95 h, range 1.82-6.48 h) (P less than 0.05). This prolongation of the elimination half-life was due to an increased volume of distribution (Vd beta) in the obese group (42.81 1, range 35.49-51.90 l) vs 33.70 l range (17.76-50.62 l) (P less than 0.05). There was therefore no significant difference in total plasma clearance between the obese and normal groups. No correlation of ifosfamide plasma half-life was observed with total body weight (TBW) or ideal body weight (IBW). However, a significant positive correlation was observed between the percentage of IBW and plasma half-life. A strong positive correlation was observed between IBW and the plasma clearance of ifosfamide. The Vd beta correlated with both TBW and the percentage of IBW, but not with IBW itself. When Vd beta was normalised for IBW, there was a strong positive correlation with the percentage of IBW, suggesting that ifosfamide distribution into the TBW is higher than that into the IBW.", 
        "genre": "research_article", 
        "id": "sg:pub.10.1007/bf00692355", 
        "inLanguage": [
          "en"
        ], 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1088364", 
            "issn": [
              "0344-5704", 
              "1432-0843"
            ], 
            "name": "Cancer Chemotherapy and Pharmacology", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "2", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "25"
          }
        ], 
        "name": "Prolongation of ifosfamide elimination half-life in obese patients due to altered drug distribution", 
        "pagination": "139-142", 
        "productId": [
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/bf00692355"
            ]
          }, 
          {
            "name": "readcube_id", 
            "type": "PropertyValue", 
            "value": [
              "49798b658e3a8adbeaa7a0227f28af65a3a857ac8993f750d3e35a7bc163bfe3"
            ]
          }, 
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1015420877"
            ]
          }, 
          {
            "name": "nlm_unique_id", 
            "type": "PropertyValue", 
            "value": [
              "7806519"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "2557169"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/bf00692355", 
          "https://app.dimensions.ai/details/publication/pub.1015420877"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2019-04-15T09:04", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000375_0000000375/records_91469_00000000.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "http://link.springer.com/10.1007/BF00692355"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf00692355'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf00692355'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf00692355'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf00692355'


     

    This table displays all metadata directly associated to this object as RDF triples.

    243 TRIPLES      21 PREDICATES      71 URIs      35 LITERALS      23 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/bf00692355 schema:about N0f4402281eae42fd82581b82513977ae
    2 N16489946df8c4311afd94ea8e2870d26
    3 N18b6c0fe1c644d87a27c7eb9e8f17df4
    4 N19ad8f901fba448080ccc57f3fb4b9de
    5 N1c9cac8a24f84763ba1764d99fe5ad05
    6 N47b8cffaf53c421d8182c345bdd7b30a
    7 N49e7ae42d28647afaaafdb0acbdf039d
    8 N8a458d0ca2ae4f2e807400576ec74a1b
    9 N91a2b57f51194f06a4dcc652a1c99bd8
    10 Ncfb33e33b7e546e28b58737c8c5a84a5
    11 Nde81af3fdab24941abbc110fb50f966d
    12 Ne60169261a2442f0903e8d232be32038
    13 Ne6c17c78908e49b69e364a85b3c9a24d
    14 Neee183f9cf8c4558b69e8b1626896e5e
    15 anzsrc-for:11
    16 anzsrc-for:1103
    17 schema:author Na4e1bff01224446089365e9eefdf5288
    18 schema:citation sg:pub.10.1007/978-3-642-81401-3
    19 sg:pub.10.1007/bf00570489
    20 sg:pub.10.1007/bf00647438
    21 sg:pub.10.1038/clpt.1984.263
    22 sg:pub.10.1038/clpt.1985.66
    23 sg:pub.10.2165/00003088-198207020-00002
    24 sg:pub.10.2165/00003088-198611030-00002
    25 https://app.dimensions.ai/details/publication/pub.1006569257
    26 https://app.dimensions.ai/details/publication/pub.1075246971
    27 https://app.dimensions.ai/details/publication/pub.1076340409
    28 https://app.dimensions.ai/details/publication/pub.1079450294
    29 https://app.dimensions.ai/details/publication/pub.1081346306
    30 https://app.dimensions.ai/details/publication/pub.1081583236
    31 https://app.dimensions.ai/details/publication/pub.1082156052
    32 https://app.dimensions.ai/details/publication/pub.1082228972
    33 https://doi.org/10.1002/1097-0142(197805)41:5<1715::aid-cncr2820410510>3.0.co;2-x
    34 https://doi.org/10.1002/art.1780281006
    35 https://doi.org/10.1002/bmc.1130010303
    36 https://doi.org/10.1002/cpt1978234438
    37 https://doi.org/10.1002/j.1552-4604.1981.tb01769.x
    38 https://doi.org/10.1016/0006-2952(74)90318-9
    39 https://doi.org/10.1016/0305-7372(85)90011-8
    40 https://doi.org/10.1016/s0140-6736(80)92703-8
    41 https://doi.org/10.1016/s0305-7372(83)80002-4
    42 https://doi.org/10.1111/j.1365-2125.1983.tb02258.x
    43 https://doi.org/10.1111/j.1365-2125.1985.tb02799.x
    44 https://doi.org/10.1200/jco.1988.6.8.1321
    45 https://doi.org/10.1210/jcem-24-9-832
    46 schema:datePublished 1989-03
    47 schema:datePublishedReg 1989-03-01
    48 schema:description The pharmacokinetics of intravenous ifosfamide were determined in 16 patients with carcinoma of the bronchus. In all 25% (4) of these patients were obese (i.e. greater than 20% over their ideal body weight). The terminal elimination half-life (t1/2 beta) was found to be higher in the obese group than in the control group (6.36 h, range 5.77-7.45 h) vs 4.95 h, range 1.82-6.48 h) (P less than 0.05). This prolongation of the elimination half-life was due to an increased volume of distribution (Vd beta) in the obese group (42.81 1, range 35.49-51.90 l) vs 33.70 l range (17.76-50.62 l) (P less than 0.05). There was therefore no significant difference in total plasma clearance between the obese and normal groups. No correlation of ifosfamide plasma half-life was observed with total body weight (TBW) or ideal body weight (IBW). However, a significant positive correlation was observed between the percentage of IBW and plasma half-life. A strong positive correlation was observed between IBW and the plasma clearance of ifosfamide. The Vd beta correlated with both TBW and the percentage of IBW, but not with IBW itself. When Vd beta was normalised for IBW, there was a strong positive correlation with the percentage of IBW, suggesting that ifosfamide distribution into the TBW is higher than that into the IBW.
    49 schema:genre research_article
    50 schema:inLanguage en
    51 schema:isAccessibleForFree false
    52 schema:isPartOf N7e7da92be61e46479d07f45356872b0b
    53 N83c5612e40144cc7b6a52232e2124cca
    54 sg:journal.1088364
    55 schema:name Prolongation of ifosfamide elimination half-life in obese patients due to altered drug distribution
    56 schema:pagination 139-142
    57 schema:productId N0915ac06459c4f3e87b08392e7d6f915
    58 N37395b370cfc4edca812dca27bb97be8
    59 N5e86038234cd4e9fb13f830d1aad8add
    60 Nd125d9fc097247b998fc886d2084cbbb
    61 Ned537a883c9e415a9c763dc43bb81427
    62 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015420877
    63 https://doi.org/10.1007/bf00692355
    64 schema:sdDatePublished 2019-04-15T09:04
    65 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    66 schema:sdPublisher Na31d3b42c6404c36b796894a05e8a0c1
    67 schema:url http://link.springer.com/10.1007/BF00692355
    68 sgo:license sg:explorer/license/
    69 sgo:sdDataset articles
    70 rdf:type schema:ScholarlyArticle
    71 N0915ac06459c4f3e87b08392e7d6f915 schema:name doi
    72 schema:value 10.1007/bf00692355
    73 rdf:type schema:PropertyValue
    74 N0f4402281eae42fd82581b82513977ae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    75 schema:name Mesna
    76 rdf:type schema:DefinedTerm
    77 N16489946df8c4311afd94ea8e2870d26 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    78 schema:name Aged
    79 rdf:type schema:DefinedTerm
    80 N18b6c0fe1c644d87a27c7eb9e8f17df4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    81 schema:name Middle Aged
    82 rdf:type schema:DefinedTerm
    83 N19ad8f901fba448080ccc57f3fb4b9de schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    84 schema:name Time Factors
    85 rdf:type schema:DefinedTerm
    86 N1c9cac8a24f84763ba1764d99fe5ad05 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    87 schema:name Humans
    88 rdf:type schema:DefinedTerm
    89 N2fdd14961bc74b09b8c11dc5b24b9503 rdf:first sg:person.01145564236.77
    90 rdf:rest Nf7ac19c8484247e1aa1754f879b17808
    91 N37395b370cfc4edca812dca27bb97be8 schema:name dimensions_id
    92 schema:value pub.1015420877
    93 rdf:type schema:PropertyValue
    94 N47b8cffaf53c421d8182c345bdd7b30a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    95 schema:name Antineoplastic Combined Chemotherapy Protocols
    96 rdf:type schema:DefinedTerm
    97 N49e7ae42d28647afaaafdb0acbdf039d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    98 schema:name Ifosfamide
    99 rdf:type schema:DefinedTerm
    100 N5e86038234cd4e9fb13f830d1aad8add schema:name readcube_id
    101 schema:value 49798b658e3a8adbeaa7a0227f28af65a3a857ac8993f750d3e35a7bc163bfe3
    102 rdf:type schema:PropertyValue
    103 N618aae4bf199477fb725dda9579b1eff schema:name Department of Clinical Pharmacology, Christie Hospital and Holt Radium Institute, M20 9BX, Manchester, U.K.
    104 rdf:type schema:Organization
    105 N68ef86c3c14240a68c9525a519f9af9e schema:name CRC Department of Medical Oncology, Christie Hospital and Holt Radium Institute, M20 9BX, Manchester, U.K.
    106 rdf:type schema:Organization
    107 N7e7da92be61e46479d07f45356872b0b schema:volumeNumber 25
    108 rdf:type schema:PublicationVolume
    109 N83046498e024423aa40eaccf322cb7d6 schema:name CRC Department of Medical Oncology, Christie Hospital and Holt Radium Institute, M20 9BX, Manchester, U.K.
    110 rdf:type schema:Organization
    111 N83c5612e40144cc7b6a52232e2124cca schema:issueNumber 2
    112 rdf:type schema:PublicationIssue
    113 N89d24b146aae48c9bec8a2790b2130e3 schema:name CRC Department of Medical Oncology, Christie Hospital and Holt Radium Institute, M20 9BX, Manchester, U.K.
    114 rdf:type schema:Organization
    115 N8a458d0ca2ae4f2e807400576ec74a1b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    116 schema:name Chromatography, High Pressure Liquid
    117 rdf:type schema:DefinedTerm
    118 N91a2b57f51194f06a4dcc652a1c99bd8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    119 schema:name Obesity
    120 rdf:type schema:DefinedTerm
    121 N926278e337ca4fb1a3495d5bc9876f2c rdf:first sg:person.01036570730.14
    122 rdf:rest rdf:nil
    123 Na31d3b42c6404c36b796894a05e8a0c1 schema:name Springer Nature - SN SciGraph project
    124 rdf:type schema:Organization
    125 Na4e1bff01224446089365e9eefdf5288 rdf:first sg:person.015422476532.69
    126 rdf:rest Nb0f09da4330941f7a4b34a846395ecb4
    127 Nb0f09da4330941f7a4b34a846395ecb4 rdf:first sg:person.01041042433.15
    128 rdf:rest N2fdd14961bc74b09b8c11dc5b24b9503
    129 Ncfb33e33b7e546e28b58737c8c5a84a5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    130 schema:name Adult
    131 rdf:type schema:DefinedTerm
    132 Nd125d9fc097247b998fc886d2084cbbb schema:name nlm_unique_id
    133 schema:value 7806519
    134 rdf:type schema:PropertyValue
    135 Nd64294b5c4414f4baae734b6fd2eea7c schema:name Department of Clinical Pharmacology, Christie Hospital and Holt Radium Institute, M20 9BX, Manchester, U.K.
    136 rdf:type schema:Organization
    137 Nde81af3fdab24941abbc110fb50f966d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    138 schema:name Lung Neoplasms
    139 rdf:type schema:DefinedTerm
    140 Ne60169261a2442f0903e8d232be32038 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    141 schema:name Carcinoma, Non-Small-Cell Lung
    142 rdf:type schema:DefinedTerm
    143 Ne6c17c78908e49b69e364a85b3c9a24d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    144 schema:name Half-Life
    145 rdf:type schema:DefinedTerm
    146 Ned537a883c9e415a9c763dc43bb81427 schema:name pubmed_id
    147 schema:value 2557169
    148 rdf:type schema:PropertyValue
    149 Neee183f9cf8c4558b69e8b1626896e5e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    150 schema:name Tissue Distribution
    151 rdf:type schema:DefinedTerm
    152 Nf7ac19c8484247e1aa1754f879b17808 rdf:first sg:person.015365270024.60
    153 rdf:rest N926278e337ca4fb1a3495d5bc9876f2c
    154 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    155 schema:name Medical and Health Sciences
    156 rdf:type schema:DefinedTerm
    157 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
    158 schema:name Clinical Sciences
    159 rdf:type schema:DefinedTerm
    160 sg:journal.1088364 schema:issn 0344-5704
    161 1432-0843
    162 schema:name Cancer Chemotherapy and Pharmacology
    163 rdf:type schema:Periodical
    164 sg:person.01036570730.14 schema:affiliation N618aae4bf199477fb725dda9579b1eff
    165 schema:familyName Wilkinson
    166 schema:givenName P. M.
    167 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036570730.14
    168 rdf:type schema:Person
    169 sg:person.01041042433.15 schema:affiliation Nd64294b5c4414f4baae734b6fd2eea7c
    170 schema:familyName Margison
    171 schema:givenName J. M.
    172 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01041042433.15
    173 rdf:type schema:Person
    174 sg:person.01145564236.77 schema:affiliation N68ef86c3c14240a68c9525a519f9af9e
    175 schema:familyName Cerny
    176 schema:givenName T.
    177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145564236.77
    178 rdf:type schema:Person
    179 sg:person.015365270024.60 schema:affiliation N83046498e024423aa40eaccf322cb7d6
    180 schema:familyName Thatcher
    181 schema:givenName N.
    182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015365270024.60
    183 rdf:type schema:Person
    184 sg:person.015422476532.69 schema:affiliation N89d24b146aae48c9bec8a2790b2130e3
    185 schema:familyName Lind
    186 schema:givenName M. J.
    187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015422476532.69
    188 rdf:type schema:Person
    189 sg:pub.10.1007/978-3-642-81401-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006569257
    190 https://doi.org/10.1007/978-3-642-81401-3
    191 rdf:type schema:CreativeWork
    192 sg:pub.10.1007/bf00570489 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007459702
    193 https://doi.org/10.1007/bf00570489
    194 rdf:type schema:CreativeWork
    195 sg:pub.10.1007/bf00647438 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022888188
    196 https://doi.org/10.1007/bf00647438
    197 rdf:type schema:CreativeWork
    198 sg:pub.10.1038/clpt.1984.263 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006768078
    199 https://doi.org/10.1038/clpt.1984.263
    200 rdf:type schema:CreativeWork
    201 sg:pub.10.1038/clpt.1985.66 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003361973
    202 https://doi.org/10.1038/clpt.1985.66
    203 rdf:type schema:CreativeWork
    204 sg:pub.10.2165/00003088-198207020-00002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046808650
    205 https://doi.org/10.2165/00003088-198207020-00002
    206 rdf:type schema:CreativeWork
    207 sg:pub.10.2165/00003088-198611030-00002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003570732
    208 https://doi.org/10.2165/00003088-198611030-00002
    209 rdf:type schema:CreativeWork
    210 https://app.dimensions.ai/details/publication/pub.1006569257 schema:CreativeWork
    211 https://app.dimensions.ai/details/publication/pub.1075246971 schema:CreativeWork
    212 https://app.dimensions.ai/details/publication/pub.1076340409 schema:CreativeWork
    213 https://app.dimensions.ai/details/publication/pub.1079450294 schema:CreativeWork
    214 https://app.dimensions.ai/details/publication/pub.1081346306 schema:CreativeWork
    215 https://app.dimensions.ai/details/publication/pub.1081583236 schema:CreativeWork
    216 https://app.dimensions.ai/details/publication/pub.1082156052 schema:CreativeWork
    217 https://app.dimensions.ai/details/publication/pub.1082228972 schema:CreativeWork
    218 https://doi.org/10.1002/1097-0142(197805)41:5<1715::aid-cncr2820410510>3.0.co;2-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1001078895
    219 rdf:type schema:CreativeWork
    220 https://doi.org/10.1002/art.1780281006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001231073
    221 rdf:type schema:CreativeWork
    222 https://doi.org/10.1002/bmc.1130010303 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052597820
    223 rdf:type schema:CreativeWork
    224 https://doi.org/10.1002/cpt1978234438 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020458889
    225 rdf:type schema:CreativeWork
    226 https://doi.org/10.1002/j.1552-4604.1981.tb01769.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1049461852
    227 rdf:type schema:CreativeWork
    228 https://doi.org/10.1016/0006-2952(74)90318-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013048117
    229 rdf:type schema:CreativeWork
    230 https://doi.org/10.1016/0305-7372(85)90011-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001184954
    231 rdf:type schema:CreativeWork
    232 https://doi.org/10.1016/s0140-6736(80)92703-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009504814
    233 rdf:type schema:CreativeWork
    234 https://doi.org/10.1016/s0305-7372(83)80002-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035035103
    235 rdf:type schema:CreativeWork
    236 https://doi.org/10.1111/j.1365-2125.1983.tb02258.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1002330203
    237 rdf:type schema:CreativeWork
    238 https://doi.org/10.1111/j.1365-2125.1985.tb02799.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1015146573
    239 rdf:type schema:CreativeWork
    240 https://doi.org/10.1200/jco.1988.6.8.1321 schema:sameAs https://app.dimensions.ai/details/publication/pub.1079730253
    241 rdf:type schema:CreativeWork
    242 https://doi.org/10.1210/jcem-24-9-832 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064305784
    243 rdf:type schema:CreativeWork
     




    Preview window. Press ESC to close (or click here)


    ...